Restricted TRBV repertoire in CD4 + and CD8 + T-cell subsets from CML patients

Hematology

Volumn 16, Issue 1, 2011, Pages 43-49

  Li, Yangqiu ^a,b   Geng, Suxia ^a,c   Du, Xin ^c   Chen, Shaohua ^a   Yang, Lijian ^a   Wu, Xiuli ^a   Li, Bo ^a   Schmidt, Christian A ^d   Przybylski, Grzegorz K ^d,e  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

^c GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^d UNIVERSITY OF GREIFSWALD   (Germany)

^e INSTITUTE OF HUMAN GENETICS   (Poland)

Author keywords

Chronic myeloid leukemia; Clonal expansion; T cells; TRVB repertoire

Indexed keywords

LEUKEMIA ANTIGEN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PATIENT; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELLULAR IMMUNODEFICIENCY; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; GENES, T-CELL RECEPTOR BETA; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTE SUBSETS; YOUNG ADULT;

EID: 79551691104     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453311X12902908411634     Document Type: Article

References (24)

1. Jabbour E, Cortes J, Kantarjian H. Treatment selection after imatinib resistance in chronic myeloid leukemia. Target Oncol 2009;4:3-10.
2. Hadden JW. Immunodeficiency and cancer: prospects for correction. Int Immunopharmacol 2003;3:1061-71.
3. Costello RT, Rey J, Fauriat C, Gastaut JA, Olive D. New approaches in the immunotherapy of haematological malignancies. Eur J Haematol 2003;70:333-45.
4. Pannetier C, Even J, Kourilsky P. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today 1995;16:176-81.
5. Sensi M, Parmiani G. Analysis of TCR usage in human tumors: a new tool for assessing tumor-specific immune response. Immunol Today 1995;16:588-95.
6. Lozeron P, Chabas D, Duprey B, Lyon-Caen O, Liblau R. T cell receptor V beta 5 and V beta 17 clonal diversity in cerebrospinal fluid and peripheral blood lymphocytes of multiple sclerosis patients. Mult Scler 1998;4:154-61.
7. Puisieux I, Even J, Pannetier C, Jotereau F, Favrot M, Kourilsky P. Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J Immunol 1994;153:2807-18.
8. Li Y. Leukemia associated clonal expansion TCR Vβ subfamily T cells. Hematology 2003;8:375-84.
9. Li Y, Yang L, Chen S, Zhang Y, Wu X. The TCR Vbeta repertoire usage of T-cells from cord blood induced by chronic myelogenous leukemia associated antigen. Hematology 2005;10:387-92.
10. RezvanyM, Jeddi-TehraniM, Osterborg A, Kimby E,Wigzell H, Mellstedt H. Oligoclonal TCR BV gene usage in B-cell chronic lymphocytic leukemia: major perturbations are preferentially seen within the CD4 T-cell subset. Blood 1999;94:1063-9.
11. Rezvany MR, Jeddi-Tehrani M, Wigzell H, Osterborg A, Mellstedt H. Leukemia-associated monoclonal and oligoclonal TCR-BV use in patients with B-cell chronic lymphocytic leukemia. Blood 2003;101:1063-70.
12. thor Straten P, Guldberg P, Gronbeak K, Hansen MR, Kirkin AF, Seremet T, et al. In situ T cell responses against melanoma comprise high numbers of locally expanded T cell clonatypes. J Immunol 1999;163:443-7.
13. Mami-Chouaib F, Echchakir H, Dorothée G, Vergnon I, Chouaib S. Antitumor cytotoxic T-lymphocyte response in human lung carcinoma: identification of a tumor-associated antigen. Immunol Rev 2002;188:114-21.
14. Geng SX, Li YQ, Chen SH, Yang LJ, Yin QS, Wu XL, et al. Peripheral blood naive T cell level and its T cell receptor Vbeta repertoire usage profile in patients with chronic myelogenous leukemia. Zhonghua Xue Ye Xue Za Zhi 2005;26:413-6. (Chinese).
15. Li Y, Chen S, Yang L, Yin Q, Geng S, Wu X, et al. TRAV and TRBV repertoire, clonality and the proliferative history of umbilical cord blood T cells. Transplant Immunol 2007;18:151-8.
16. Gorski J, Yassai M, Zhu X, Kissela B, Kissella B. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. J Immunol 1994;152:5109-19.
17. Assaf C, Hummel M, Dippel E, Goerdt S, Muller HH, Anagnostopoulos I, et al. High detection rate of T-cell receptor beta chain rearrangements in T-cell lymphoproliferations by family specific polymerase chain reaction in combination with the GeneScan technique and DNA sequencing. Blood 2000;96:640-6.
18. Farace F, Orlanducci F, Dietrich PY, Gaudin C, Angevin E, Courtier MH, et al. T cell repertoire in patients with B chronic lymphocytic leukemia. Evidence for multiple in vivo T cell clonal expansions. J Immunol 1994;153:4281-90.
19. Coleman S, Perera P, Fisher J, Hoy T, Burnett AK, Lim SH. Abnormal TCR V beta repertoire in patients with chronic myeloid leukaemia. Br J Haematol 1995;90:358-63.
20. + T cell subsets in chronic lymphocytic leukemia. J Immunol 1997;158:1482-9.
21. Kluin-Nelemans JC, Kester MG, Melenhorst JJ, Landegent JE, van de Corput L, Willemze R, et al. Persistent clonal excess and skewed T-cell repertoire in T cells from patients with hairy cell leukemia. Blood 1996;87:3795-802.
22. Alatrakchi N, Farace F, Frau E, Carde P, Munck JN, Triebel F. T-cell clonal expansion in patients with B-cell lymphoproliferative disorders. J Immunother 1998;21:363-70.
23. Li YQ, Yang LJ, Chen SH, Zhang YP, Zhang XL, Luo GX. TCR Vβ repertoire usage and clonal expansion of T cells in chronic myelogenous leukemia. Chin Med J 2004;117:840-3.
24. Brown RD, Yuen E, Nelson M, Gibson J, Joshua D. The prognostic significance of T cell receptor beta gene rearrangements and idotype-reactive T cells in multiple myeloma. Leukemia 1997;11:1312-7.